Stock MTNB MATINAS BIOPHARMA HOLDINGS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Matinas BioPharma Holdings, Inc.

Equities

MTNB

US5768101058

Market Closed - Nyse
Other stock markets
 04:00:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
0.1789 USD -1.43% Intraday chart for Matinas BioPharma Holdings, Inc. -4.69% -17.25%
Mar. 27 Transcript : Matinas BioPharma Holdings, Inc., 2023 Earnings Call, Mar 27, 2024
Mar. 27 Matinas BioPharma Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Evolution of the average Target Price on Matinas BioPharma Holdings, Inc.

Price target over the last 5 years

History of analyst recommendation changes

1efa20382.6Kg6tzeWXuUSAZzMSKmT0m0QMl8aXeoSdSXgngIBASk.25975WP8B4Rkdtu1Dtvgvz9zcSsrF617LFeB2UdmWXvd-m7NVtcnhGdj8w~366468f73b49e0ec2b3c378703c7a309

Analyst Recommendations on Matinas BioPharma Holdings, Inc.

MATINAS BIOPHARMA : Piper Sandler Cuts Matinas BioPharma Holdings to Neutral From Overweight, Price Target to $0.90 From $4 MT
MATINAS BIOPHARMA : HC Wainwright Adjusts Price Target on Matinas BioPharma Holdings to $3 From $4, Maintains Buy Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
0.1789 USD
Average target price
0.8667 USD
Spread / Average Target
+384.44%
High Price Target
1 USD
Spread / Highest target
+458.97%
Low Price Target
0.6 USD
Spread / Lowest Target
+235.38%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Matinas BioPharma Holdings, Inc.

Piper Sandler
HC Wainwright

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. MTNB Stock
  4. Consensus Matinas BioPharma Holdings, Inc.